Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
SURPASS-2: The Only Head-to-Head Trial The SURPASS-2 trial (NEJM, 2021) is the most important study in this comparison because it directly tested tirzepatide against semaglutide in 1,879 patients with type 2 diabetes over 40 weeks
A randomized clinical trial to determine the effect of dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonist-mediated weight loss and diet on crohn's disease clinical response: a pilot study
People with a history of severe gastroparesis, or stomach paralysis, should not use the drug, the FDA says
If weight management is your primary goal, Mounjaro is the appropriate option
10.1016/j.molmet.2020.100978 Mol
The science isn't even close
US$ 21.47
US$ 27.38
US$ 29.26
